London Daily

Focus on the big picture.
Saturday, Jul 26, 2025

Oxford research suggests risk of rare blood clotting HIGHER for Covid-19 than for VACCINES

Oxford research suggests risk of rare blood clotting HIGHER for Covid-19 than for VACCINES

Researchers at the University of Oxford say Covid-19 leads to a risk of rare blood clots that's several-times higher than that of current vaccines, amid concerns that the jabs may be to blame for the potentially deadly condition.
The report released on Thursday says the risk of the rare condition known as cerebral venous thrombosis (CVT) following Covid-19 infection is “around 100 times greater than normal” and “several times higher” than it is post-vaccination or after flu.

Researchers looked at health records of 500,000 Covid-19 patients to estimate the absolute incidence of CVT in the two weeks following Covid-19 diagnosis, flu, or vaccination against coronavirus. They found that clotting is around eight times more likely to occur after contracting Covid-19 than after immunization with the AZ-Oxford Covid-19 vaccine. Compared to the vaccines made by Pfizer or Moderna, the risk of a CVT from Covid-19 is about 10 times greater.

The researchers, however, call for a cautious interpretation of the comparisons since data is still coming in.

“There are concerns about possible associations between vaccines, and CVT, causing governments and regulators to restrict the use of certain vaccines. Yet, one key question remained unknown: ‘What is the risk of CVT following a diagnosis of Covid-19?’” says Professor of Psychiatry and Head of the Translational Neurobiology Group at the University of Oxford Paul Harrison.

Some countries have restricted the use of the Oxford-AstraZeneca vaccine – which was renamed Vaxzevria – to certain age groups after the European Medicines Agency confirmed the vaccine’s possible links to cases of blood clotting, several of which were fatal. Denmark halted the use of the jab altogether.

Meanwhile, another EMA-approved vaccine, Johnson & Johnson's, is being investigated in the US and Europe following cases of blood clotting and at least one death.

Both vaccines are based on a similar method, known as adenoviral vectors. Regulators and researchers are working to find out whether the incidences of blood clotting are caused by an immune response to the adenovirus vaccines
Newsletter

Related Articles

0:00
0:00
Close
Deputy attorney general's second day of meeting with Ghislaine Maxwell has concluded
Controversial March in Switzerland Features Men Dressed in Nazi Uniforms
Politics is a good business: Barack Obama’s Reported Net Worth Growth, 1990–2025
Thai Civilian Death Toll Rises to 12 in Cambodian Cross-Border Attacks
TSUNAMI: Trump Just Crossed the Rubicon—And There’s No Turning Back
Over 120 Criminal Cases Dismissed in Boston Amid Public Defender Shortage
UN's Top Court Declares Environmental Protection a Legal Obligation Under International Law
"Crazy Thing": OpenAI's Sam Altman Warns Of AI Voice Fraud Crisis In Banking
The Podcaster Who Accidentally Revealed He Earns Over $10 Million a Year
Trump Announces $550 Billion Japanese Investment and New Trade Agreements with Indonesia and the Philippines
US Treasury Secretary Calls for Institutional Review of Federal Reserve Amid AI‑Driven Growth Expectations
UK Government Considers Dropping Demand for Apple Encryption Backdoor
Severe Flooding in South Korea Claims Lives Amid Ongoing Rescue Operations
Japanese Man Discovers Family Connection Through DNA Testing After Decades of Separation
Russia Signals Openness to Ukraine Peace Talks Amid Escalating Drone Warfare
Switzerland Implements Ban on Mammography Screening
Japanese Prime Minister Vows to Stay After Coalition Loses Upper House Majority
Pogacar Extends Dominance with Stage Fifteen Triumph at Tour de France
CEO Resigns Amid Controversy Over Relationship with HR Executive
Man Dies After Being Pulled Into MRI Machine Due to Metal Chain in New York Clinic
NVIDIA Achieves $4 Trillion Valuation Amid AI Demand
US Revokes Visas of Brazilian Corrupted Judges Amid Fake Bolsonaro Investigation
U.S. Congress Approves Rescissions Act Cutting Federal Funding for NPR and PBS
North Korea Restricts Foreign Tourist Access to New Seaside Resort
Brazil's Supreme Court Imposes Radical Restrictions on Former President Bolsonaro
Centrist Criticism of von der Leyen Resurfaces as she Survives EU Confidence Vote
Judge Criticizes DOJ Over Secrecy in Dropping Charges Against Gang Leader
Apple Closes $16.5 Billion Tax Dispute With Ireland
Von der Leyen Faces Setback Over €2 Trillion EU Budget Proposal
UK and Germany Collaborate on Global Military Equipment Sales
Trump Plans Over 10% Tariffs on African and Caribbean Nations
Flying Taxi CEO Reclaims Billionaire Status After Stock Surge
Epstein Files Deepen Republican Party Divide
Zuckerberg Faces $8 Billion Privacy Lawsuit From Meta Shareholders
FIFA Pressured to Rethink World Cup Calendar Due to Climate Change
SpaceX Nears $400 Billion Valuation With New Share Sale
Microsoft, US Lab to Use AI for Faster Nuclear Plant Licensing
Trump Walks Back Talk of Firing Fed Chair Jerome Powell
Zelensky Reshuffles Cabinet to Win Support at Home and in Washington
"Can You Hit Moscow?" Trump Asked Zelensky To Make Putin "Feel The Pain"
Irish Tech Worker Detained 100 days by US Authorities for Overstaying Visa
Dimon Warns on Fed Independence as Trump Administration Eyes Powell’s Succession
Church of England Removes 1991 Sexuality Guidelines from Clergy Selection
Superman Franchise Achieves Success with Latest Release
Hungary's Viktor Orban Rejects Agreements on Illegal Migration
Jeff Bezos Considers Purchasing Condé Nast as a Wedding Gift
Ghislaine Maxwell Says She’s Ready to Testify Before Congress on Epstein’s Criminal Empire
Bal des Pompiers: A Celebration of Community and Firefighter Culture in France
FBI Chief Kash Patel Denies Resignation Speculations Amid Epstein List Controversy
Air India Pilot’s Mental Health Records Under Scrutiny
×